In the debate over prescription drug prices, one group is being overlooked: people with rare diseases. The needs of these patients, who rely on specialty medications for their lives and livelihoods, must not be sacrificed in the quest to bring down drug costs.
How can President Trump and Health and Human Services Secretary Alex Azar deliver on their new “American Patients First” plan to reduce prescription drug costs?
What good is my health insurance if my copays and deductibles are so high that it doesn’t offer me any financial protection?
The American Cancer Society estimates that 1.7 million Americans will be newly diagnosed with cancer this year. Will you be one of them?